<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04067427</url>
  </required_header>
  <id_info>
    <org_study_id>MAF2019</org_study_id>
    <nct_id>NCT04067427</nct_id>
  </id_info>
  <brief_title>Reducing Recurrence of Symptomatic Atrial Fibrillation After Catheter Ablation by App-based Mental Training</brief_title>
  <acronym>Mental-AF</acronym>
  <official_title>To Reduce Recurrence of Symptomatic Atrial Fibrillation and Improve Quality of Life After Catheter Ablation for Atrial Fibrillation by App-based Mental Training (Mental AF)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Leipzig Heart Institute GmbH</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Heart Center Leipzig - University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Leipzig Heart Institute GmbH</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Atrial fibrillation (AF) is one of the most common heart rhythm disorders and it is
      associated with a variety of symptoms leading to a considerable deterioration in quality of
      life. The Mental-AF trial is intended to inquire if an app-based mental training can reduce
      the occurrence of symptomatic AF episodes within the blanking period, i.e. the first three
      months after catheter ablation for AF.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To explore the potential of a daily app-based mindfulness mental training in improving AF
      symptoms, assessed by self-reported outcome measures, i.e. the AF 6 questionnaire, AF Effect
      on QualiTy of Life (AFEQT) and Patient Reported Outcome Measurement Information System
      (PROMIS) Global Health questionnaires, as well as in reducing AF burden in 7-day-Holter,
      within the first 12 weeks following AF ablation.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 16, 2019</start_date>
  <completion_date type="Anticipated">September 2021</completion_date>
  <primary_completion_date type="Anticipated">June 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Atrial Fibrillation (AF) 6 questionnaire score</measure>
    <time_frame>12 weeks, assessed weekly</time_frame>
    <description>Atrial fibrillation specific symptomatic outcome defined by AF 6 sum scores during the first 12 weeks following AF ablation, based on a 10-point Likert scale, ranging from 0 (no symptoms) to 10 (severe symptoms), sum scores ranging from 0 to 60.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Atrial Fibrillation Effect on QualiTy of Life (AFEQT) score</measure>
    <time_frame>Follow up (3 months)</time_frame>
    <description>Effects of AF on quality of Life, assessed by a 20-item questionnaire with 4 conceptual domains (daily Activities, treatment concern, symptoms and treatment satisfaction) on a 7-point Likert scale, responses ranging from 1 (no symptoms/limitations) to 7 (most severe limitations/symptoms), higher scores indicating better health status, the raw scores can be transformed to a 0 to 100 scale adjusting for missing data</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient-Reported Outcome Measurement Information System (PROMIS) Global Health 10 score</measure>
    <time_frame>Follow up (3 months)</time_frame>
    <description>PROMIS Global Health questionnaire for the assessment of physical and mental health domains by 10 items using a 5-point Likert scale, ranging from (5) excellent to (1) poor. Higher scores indicate a healthier patient.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Atrial fibrillation burden</measure>
    <time_frame>Follow up (3 months)</time_frame>
    <description>Time in AF as assessed in 7-day-Holter</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart Rate</measure>
    <time_frame>Follow up (3 months)</time_frame>
    <description>Heart Rate during blood pressure measurement</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>Follow up (3 months)</time_frame>
    <description>Office blood pressure measurement of diastolic and systolic blood pressure</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">164</enrollment>
  <condition>Paroxysmal Atrial Fibrillation</condition>
  <condition>Persistent Atrial Fibrillation</condition>
  <condition>Mediation</condition>
  <arm_group>
    <arm_group_label>Mental training</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>AF ablation followed by 3 months of a daily app-based mental training for 10 to 15 minutes per session. AF 6 questionnaire will be answered weekly via the Mental-AF webpage.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>AF ablation without subsequent mental training. AF 6 questionnaire will be answered weekly via the Mental-AF webpage.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Mental training</intervention_name>
    <description>App-based mental training</description>
    <arm_group_label>Mental training</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients undergoing AF ablation with symptomatic paroxysmal or chronic atrial
             fibrillation (EHRA II-IV)

          -  Availability of smart phone with the capability to run android 5 or iOS 9 or newer
             versions

          -  Capability to use mobile phone applications

          -  Internet access

          -  Consent to study participation

        Exclusion Criteria:

          -  Patients &lt; 18 years of age

          -  Unavailability of smart phone running at least Android 5 or iOS 9

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>88 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Julia A Lurz</last_name>
    <role>Principal Investigator</role>
    <affiliation>Herzzentrum Leipzig, Str√ºmpellstr. 39, 04289 Leipzig, Germany</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Julia A Lurz, MD</last_name>
    <phone>+49341865252085</phone>
    <email>julia.lurz@medizin.uni-leipzig.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Leipzig Heart Institute</name>
      <address>
        <city>Leipzig</city>
        <state>Saxony</state>
        <zip>04289</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julia A Lurz, MD</last_name>
      <phone>+49341865252085</phone>
      <email>julia.lurz@medizin.uni-leipzig.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>August 15, 2019</study_first_submitted>
  <study_first_submitted_qc>August 22, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 26, 2019</study_first_posted>
  <last_update_submitted>October 21, 2019</last_update_submitted>
  <last_update_submitted_qc>October 21, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 23, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
    <mesh_term>Recurrence</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

